These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 10773819

  • 1. Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance.
    Fernández Y, España L, Mañas S, Fabra A, Sierra A.
    Cell Death Differ; 2000 Apr; 7(4):350-9. PubMed ID: 10773819
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of Bcl-xL in human breast cancer cells enhances organ-selective lymph node metastasis.
    España L, Fernández Y, Rubio N, Torregrosa A, Blanco J, Sierra A.
    Breast Cancer Res Treat; 2004 Sep; 87(1):33-44. PubMed ID: 15377849
    [Abstract] [Full Text] [Related]

  • 3. Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents.
    Fan S, Wang JA, Yuan RQ, Rockwell S, Andres J, Zlatapolskiy A, Goldberg ID, Rosen EM.
    Oncogene; 1998 Jul 16; 17(2):131-41. PubMed ID: 9674697
    [Abstract] [Full Text] [Related]

  • 4. Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis.
    Dole MG, Jasty R, Cooper MJ, Thompson CB, Nuñez G, Castle VP.
    Cancer Res; 1995 Jun 15; 55(12):2576-82. PubMed ID: 7780971
    [Abstract] [Full Text] [Related]

  • 5. Bcl-2-mediated cell survival promotes metastasis of EpH4 betaMEKDD mammary epithelial cells.
    Pinkas J, Martin SS, Leder P.
    Mol Cancer Res; 2004 Oct 15; 2(10):551-6. PubMed ID: 15498929
    [Abstract] [Full Text] [Related]

  • 6. Astrocyte-derived cytokines contribute to the metastatic brain specificity of breast cancer cells.
    Sierra A, Price JE, García-Ramirez M, Méndez O, López L, Fabra A.
    Lab Invest; 1997 Oct 15; 77(4):357-68. PubMed ID: 9354770
    [Abstract] [Full Text] [Related]

  • 7. Bcl-XL protects cancer cells from p53-mediated apoptosis.
    Schott AF, Apel IJ, Nuñez G, Clarke MF.
    Oncogene; 1995 Oct 05; 11(7):1389-94. PubMed ID: 7478561
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice.
    Bargou RC, Wagener C, Bommert K, Mapara MY, Daniel PT, Arnold W, Dietel M, Guski H, Feller A, Royer HD, Dörken B.
    J Clin Invest; 1996 Jun 01; 97(11):2651-9. PubMed ID: 8647960
    [Abstract] [Full Text] [Related]

  • 9. Involvement of bcl-2 and p21waf1 proteins in response of human breast cancer cell clones to Tomudex.
    Orlandi L, Bearzatto A, Abolafio G, De Marco C, Daidone MG, Zaffaroni N.
    Br J Cancer; 1999 Sep 01; 81(2):252-60. PubMed ID: 10496350
    [Abstract] [Full Text] [Related]

  • 10. Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines.
    Jackson JG, Zhang X, Yoneda T, Yee D.
    Oncogene; 2001 Nov 01; 20(50):7318-25. PubMed ID: 11704861
    [Abstract] [Full Text] [Related]

  • 11. Antisense RNA down-regulation of bcl-xL Expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents.
    Vilenchik M, Raffo AJ, Benimetskaya L, Shames D, Stein CA.
    Cancer Res; 2002 Apr 01; 62(7):2175-83. PubMed ID: 11929841
    [Abstract] [Full Text] [Related]

  • 12. Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization.
    Hafid-Medheb K, Poindessous-Jazat V, Augery-Bourget Y, Hanania N, Robert-Lézénès J.
    Cell Death Differ; 1999 Feb 01; 6(2):166-74. PubMed ID: 10200563
    [Abstract] [Full Text] [Related]

  • 13. Modulation of apoptosis by endogenous Bcl-xL expression in MKN-45 human gastric cancer cells.
    Kondo S, Shinomura Y, Kanayama S, Higashimoto Y, Kiyohara T, Zushi S, Kitamura S, Ueyama H, Matsuzawa Y.
    Oncogene; 1998 Nov 19; 17(20):2585-91. PubMed ID: 9840921
    [Abstract] [Full Text] [Related]

  • 14. Interconnections between E2-dependent regulation of cell cycle progression and apoptosis in MCF-7 tumors growing on nude mice.
    Truchet I, Jozan S, Guerrin M, Mazzolini L, Vidal S, Valette A.
    Exp Cell Res; 2000 Feb 01; 254(2):241-8. PubMed ID: 10640422
    [Abstract] [Full Text] [Related]

  • 15. [The effects of antisense oligonucleotides bcl-2/bcl-xl and bcl-2 on proliferation and apoptosis of breast cancer cells].
    Ma C, Xie JW, Kuang AR, Huang R, Tang GS.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep 01; 40(5):780-3. PubMed ID: 19950582
    [Abstract] [Full Text] [Related]

  • 16. Suppression of protein kinase Calpha triggers apoptosis through down-regulation of Bcl-xL in a rat hepatic epithelial cell line.
    Hsieh YC, Jao HC, Yang RC, Hsu HK, Hsu C.
    Shock; 2003 Jun 01; 19(6):582-7. PubMed ID: 12785016
    [Abstract] [Full Text] [Related]

  • 17. Effects of Bcl-2 and Bcl-XL protein levels on chemoresistance of hepatoblastoma HepG2 cell line.
    Luo D, Cheng SC, Xie H, Xie Y.
    Biochem Cell Biol; 2000 Jun 01; 78(2):119-26. PubMed ID: 10874473
    [Abstract] [Full Text] [Related]

  • 18. Expression of Siva-1 protein or its putative amphipathic helical region enhances cisplatin-induced apoptosis in breast cancer cells: effect of elevated levels of BCL-2.
    Chu F, Barkinge J, Hawkins S, Gudi R, Salgia R, Kanteti PV.
    Cancer Res; 2005 Jun 15; 65(12):5301-9. PubMed ID: 15958577
    [Abstract] [Full Text] [Related]

  • 19. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.
    Walczak H, Bouchon A, Stahl H, Krammer PH.
    Cancer Res; 2000 Jun 01; 60(11):3051-7. PubMed ID: 10850456
    [Abstract] [Full Text] [Related]

  • 20. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
    Hayashi K, Goodison S, Urquidi V, Tarin D, Lotan R, Tahara E.
    Int J Oncol; 2003 Mar 01; 22(3):623-9. PubMed ID: 12579317
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.